Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Gains from Investment Securities (2021 - 2025)

Core Scientific (CORZW) has disclosed Gains from Investment Securities for 5 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 17.19% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, up 179.92% year-over-year, with the annual reading at $5.0 million for FY2025, 17.19% down from the prior year.
  • Gains from Investment Securities hit $5.0 million in Q4 2025 for Core Scientific, up from -$300000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $43.4 million in Q4 2022 to a low of -$22.2 million in Q2 2022.
  • Historically, Gains from Investment Securities has averaged $1.4 million across 5 years, with a median of -$57500.0 in 2021.
  • Biggest five-year swings in Gains from Investment Securities: surged 73418.64% in 2022 and later tumbled 1654.48% in 2025.
  • Year by year, Gains from Investment Securities stood at $59000.0 in 2021, then soared by 73418.64% to $43.4 million in 2022, then tumbled by 91.57% to $3.7 million in 2023, then soared by 65.06% to $6.0 million in 2024, then fell by 17.19% to $5.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CORZW at $5.0 million in Q4 2025, -$300000.0 in Q3 2025, and -$4.2 million in Q2 2025.